Please use this identifier to cite or link to this item:
|Type:||Artigo de periódico|
|Title:||Quantification of dapaconazole in human plasma using high-performance liquid chromatography coupled to tandem mass spectrometry: Application to a phase I study|
|Author:||de Moraes, FC|
De Nucci, G
|Abstract:||A simple, selective and sensitive method based on high-performance liquid chromatography coupled to tandem mass spectrometry (HPLC-MS/MS) has been developed for the determination of dapacona-zole in human plasma using tioconazole as internal standard. The drugs were extracted from plasma by liquid-liquid extraction with ether/hexane (80/20, v/v). The chromatography separation was performed on a Genesis((R)) C18 reversed phase analytical column 4 mu m (100 x 2.1 mm i.d.) with a mobile phase of methanol/acetonitrile/water (80/10/10, v/v/v) + ammonium acetate (0.5 mM). Dapaconazole was quantified using a mass spectrometer with an electrospray source in the ESI positive mode (ES+) configured for multiple reaction monitoring (MRM) to monitor the transitions 415.1 > 159.2 and 387.0 > 131.0 for dapaconazole and tioconazole, respectively. The method had a chromatography run time of 3.8 min and a linear calibration curve over the range 0.2-100 ng/mL (r=0.9998). The lower limit of quantification (LLOQ) was 0.2 ng/mL. The precision and accuracy values of the assay were within +/- 10%. The stability tests indicate no significant degradation under the conditions of the experiment. This method was used for a phase I study of topical administration of dapaconazole tosylate in healthy human male volunteers. (C) 2014 Elsevier B.V. All rights reserved.|
|Editor:||Elsevier Science Bv|
|Appears in Collections:||Unicamp - Artigos e Outros Documentos|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.